机器人手术治疗小肠梗阻:ACS-NSQIP数据库倾向性评分匹配分析
基于ACS-NSQIP数据库2022-2023年22177例粘连性小肠梗阻手术的回顾性队列研究,其中开腹15246例、腹腔镜6224例、机器人707例。倾向性评分1:1:1匹配后每组701例,机器人组中位住院时间最短(2 vs 3 vs 6天,p<0.001),但手术时间最长(130 vs 76 vs 109分钟,p<0.001),30天死亡率三组相当(0.9% vs 0.7% vs 1.6%,p=0.241)。
要点
- 机器人组中位住院时间最短,但手术时间最长。
- 三种入路30天死亡率无显著差异。
- 微创入路在器官间隙感染、浅表感染、伤口裂开和再入院方面优于开腹。
核心结论
- 在倾向性评分匹配的国家级分析中,机器人手术治疗小肠梗阻与最短住院时间相关,在选定患者中安全性特征与腹腔镜手术相当。
- 两种微创入路在多个终点上均优于开腹手术,支持在有经验的中心继续评估机器人手术作为小肠梗阻的可行选择。
研究设计与样本
- 回顾性队列研究,使用ACS-NSQIP数据库(2022-2023年)。
- 通过ICD-10编码识别粘连性小肠梗阻手术患者,按手术入路分类。
- 未匹配队列采用多项logistic回归评估与入路选择相关的因素,并进行1:1:1倾向性评分匹配比较均衡组间结局。
主要发现
- 共22177例小肠梗阻手术,开腹15246例(68.7%),腹腔镜6224例(28.1%),机器人707例(3.2%)。
- 倾向性评分匹配后每组701例,机器人组中位住院时间最短(2 vs 3 vs 6天,p<0.001)。
- 机器人组手术时间最长(130 vs 76 vs 109分钟,p<0.001)。
- 30天死亡率三组相当(机器人0.9%,腹腔镜0.7%,开腹1.6%;p=0.241)。
- 两种微创入路相比开腹手术,器官间隙手术部位感染、浅表手术部位感染、伤口裂开和30天再入院率均显著更低(均p<0.001)。
关键数值与推荐
- ASA分级、腹水、播散性癌症和年龄是与手术入路选择显著相关的因素。
临床怎么用
- 在有经验的中心,机器人手术可作为选定小肠梗阻患者的可行选项,尤其关注缩短住院时间。
- 微创入路(机器人或腹腔镜)在选定患者中较开腹手术具有感染并发症和再入院方面的优势。
- 机器人手术手术时间较长,需权衡其与住院时间缩短等获益。
局限性
- 回顾性队列研究设计,存在选择偏倚可能。
- 机器人手术病例仅占3.2%,样本量相对较小。
- 全国数据库可能无法完全捕捉术者经验和中心水平等混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic surgery (RS) has expanded across elective surgical disciplines, yet its role in emergency general surgery remains poorly defined. Small bowel obstruction (SBO) is one of the most common indications for emergency abdominal surgery, and while laparoscopic surgery (LS) has demonstrated advantages over open surgery (OS), in appropriately selected patients at experienced centers, no large-scale study has evaluated robotic outcomes for this condition, partly because dedicated robotic identification variables in national databases have only recently become available. This study aimed to compare perioperative outcomes across robotic, laparoscopic, and open approaches for SBO using a nationally representative database. METHODS: A retrospective cohort study was conducted using the ACS-NSQIP database (2022-2023). Patients undergoing surgery for adhesive SBO were identified by ICD-10 codes and classified by surgical approach. Demographics, comorbidities, 30-day complications, mortality, length of stay (LOS), and operative time (OT) were analyzed. In the unmatched cohort, multinomial logistic regression assessed factors associated with approach selection. Propensity score matching (PSM) in a 1:1:1 ratio was performed to compare outcomes across balanced groups. RESULTS: Of 22,177 SBO operations, 15,246 (68.7%) were open, 6224 (28.1%) laparoscopic, and 707 (3.2%) robotic. After PSM (n = 701 per group), RS achieved the shortest median LOS (2 vs 3 vs 6 days, p < 0.001) but had the longest OT (130 vs 76 vs 109 min, p < 0.001). Thirty-day mortality was comparable across groups (RS 0.9%, LS 0.7%, OS 1.6%; p = 0.241). Both minimally invasive approaches demonstrated significantly lower rates of organ space SSI, superficial SSI, wound dehiscence, and 30-day readmission compared to OS (all p < 0.001). ASA classification, ascites, disseminated cancer, and age were among the factors significantly associated with surgical approach. CONCLUSION: In this propensity score-matched national analysis, robotic surgery for SBO was associated with the shortest hospitalization and a safety profile comparable to laparoscopic surgery in selected patients. Both minimally invasive approaches demonstrated advantages over open surgery across multiple endpoints. These findings support the continued evaluation of robotic surgery as a feasible option for SBO at experienced centers.
引用
- La Riva A, Perez-Soto RH, Aulestia J, et al. Robotic surgery for small bowel obstruction: a propensity score-matched analysis of the ACS-NSQIP database. Surg Endosc. 2026. PMID: 42675297. doi:10.1007/s00464-026-13080-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。